Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
Walk & Talk With Sentient Jet CEO
Andrew Collins, the CEO of private aviation firm Sentient Jet, joined Cheddar News anchor Hena Doba on a Walk & Talk discussing the future of business and leisure travel.
Being Prepared For a Layoff In an Uncertain Job Market
With inflationary woes and fears of recession sweeping the U.S., January has racked up the second most job cuts since the start of the pandemic. While losing a job can be daunting, there are steps employees can take to prepare for an uncertain future in their current positions.
Load More